May 2009 Volume 5, Issue 5
Volume 5, Issue 5 | May 2009
May 2009
In this Issue
Research & Development
Red ribbon allies
GSK and Pfizer merge HIV businesses to create global joint ventureSalk Institute signs R&D pact with sanofi-aventis
Collaborative agreement supports cutting-edge research, sets stage for rapid advancesMS research takes fast step forward
Fast Forward and EMD Serono collaborate on treatments for multiple sclerosisLive from New York, it’s HIV cell-to-cell transfer
Mt. Sinai, UC Davis researchers capture HIV transfer on videoStem cell therapy for hearing loss?
Sheffield University team grows stem cells into auditory cells that might one day restore hearing to the deafThe ‘father of microarrays’ attacks Parkinson’s
Arrayit and the Parkinson's Institute announce new research collaborationCancer-fighting deal easy as ADC
Millennium pays $4 million to Seattle Genetics in antibody-drug conjugate collaborationGlobal News
Galapagos, Merck sign inflammatory disease agreement
Partnership on small molecule drug candidates could be worth up to $257 millionGetting closer to the heart
Lilly forges cardiovascular research collaboration with India's Zydus Cadila worth up to $300 millionAn eye for the deal
Sanofi-aventis marches south of the border and beyondPlanting the seeds for R&D
MRC and MRC Technology launch new research center in U.K.ACADIA-Meiji Seika Kaisha deal seeks gain without the pain
ACADIA Pharmaceuticals Inc. and Meiji Seika Kaisha Ltd. announced in April their collaboration to develop and commercialize a novel class of pro-cognitive drugs called PCAPs to treat patients with schizophrenia and related disorders.Dalhousie researchers hit paydirt with discovery
A group of Canadian researchers has pinpointed a common virus that could provide a new and effective approach to eliminating breast cancer stem cells—a key tool in the battle against the deadly disease.Genomics & Proteomics
A new chapter in genomics research
Clinical Data's Cogenics division goes to Beckman Coulter in a deal worth $17 millionPutting their brains together
Gene Network Sciences and M.D. Anderson sic translational medicine on glioblastomaCatalog of human variation
Applied Biosystems, TGen team up to hasten advent of personalized medicinePrimordial biomarker
Galectin-3 discovery may lead to new cancer treatmentsHGS, Morphotek take aim at genomics-derived targets
The two companies will collaborate to discover, develop and commercialize antibodies for oncology and immunologyHeart of the matter
Absorption Systems and ChanTest team up to enhance ADME suite with tests that assess drugs’ risks for unintended cardiac effectsAutomation & Instrumentation
Biotechs buying in bulk
Massachusetts Biotechnology Council in $250 million deal with Fisher Scientific to support supply needs of the commonwealth's biotechsWorking even closer
Waters Corp. and University of Warwick turn decades-long relationship into major deal to advance adoption of novel MS technologySystems biology meets technology
Agilent Technologies and the University of Michigan join forces to stymie cell metastasisTop-down proteomics research
Bio-Rad and Bruker partner to offer new solutions for biomarker discovery and developmentBacteria biosensor makes its debut across the pond
Abbott grants LGC Europe’s first T5000 Biosensor System licenseSeahorse decides to make a splash
Company acquires BioProcessors and SimCell biomanufacturing technologyCommentary
Commentary: Biotech industry must adapt to changing political and economic landscape
A new presidential administration and a new Congress—not to mention the ever-changing economic situation on Wall Street and in financial centers around the world—are testing the speed at which biotechnology companies can react and adapt to the evolving environment.There is no place for humor in science
A decade ago, I was given the above instruction by British colleagues in response to an advertisement of my company’s products that used humor to attract attention.Editor's Focus
Lessons from AACR: Time is greatest obstacle in cancer treatment
Last month, I headed to Denver with the rest of my DDN colleagues to attend the AACR's 100th Annual Meeting, eager to learn about the latest developments in oncology research. But during my last few hours in Denver, my bubble of optimism was pricked by deflating reality.Informatics
On the path of personalized medicine
TcLand Expression taps Genedata's informatics solutions to strengthen its gene expression dataBringing on the heat
UCSC Cancer Genomics Browser uses ‘heatmaps’ to visually represent genomic and clinical data side by sideElectronic enterprise-level insight
Thermo Fisher, Symyx Technologies offer enterprise-level, electronic lab notebookGenologics’ LIMS forms SOLiD link
GenoLogics teams up with Applied Biosystems to provide an integrated lab and data management solution for the SOLiD SystemBiotech companies mix and match
Merger of Eureka and Nanobac to provide a creative way to infuse cash into bioinformatics work and more
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Accelerating RNA therapeutic testing with liver microphysiological platforms
Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
